Vflower™, First Venous Stent System by MicroPort® Endovastec, Gains Access to China’s Special Approval Procedure for Innovative Medical Devices - 11 Nov 2021
The Vflower™ Venous Stent System has been given access by NMPA to ente...MicroPort® Orthopedics Zirconium-Niobium Alloy Femoral Head Gains Access to China’s Special Approval Procedure for Innovative Medical Devices - 11 Nov 2021
A zirconium-niobium alloy femoral head, designed and developed by Micr...MicroPort® Kewei Membrane Oxygenator Gains Access to China’s Special Approval Procedure for Innovative Medical Devices - 11 Nov 2021
The Vitasprings® Spiral Diversion Integrated Membrane Oxygenator was g...MicroPort® Holds National Investigator Kick-Off Meeting for PROMISE-BIF Clinical Trial of Rapamycin Coronary Balloon Catheter - 06 Nov 2021
A national investigator kick-off meeting for the ‘PROMISE-BIF study’ w...CardioFlow Medtech Participates in the 32nd GW-ICC, Drawing Expert Attention on Clinical Application of Motorized Retrievable Valve System - 05 Nov 2021
CardioFlow Medtech hosted a symposium for its next-generation transcat...CardioFlow Medtech Increases Investment in US Structural Heart Disease Innovator 4C Medical - 05 Nov 2021
To become top shareholder and gain exclusive commercial rights in Chin...First DSA System of MicroImaging® Receives NMPA Marketing Approval - 04 Nov 2021
MicroImaging®, a subsidiary of MicroPort Scientific Corporation (Micro...MicroPort® NeuroTech Participates in 2021 OCIN as Tubridge® Used in Over 5,000 Clinical Cases - 04 Nov 2021
MicroPort® NeuroTech recently participated in the 2021 Oriental Confer...Top-tier Surgical Robot Company MicroPort MedBot Debuts on Main Board of HKEX - 02 Nov 2021
Shanghai MicroPort® MedBot (Group) Co., Ltd. (02252.HK, “MicroPort Med...MicroPort® MedBot Enters into Strategic Cooperation Agreement with South China Hospital affiliated to Shenzhen University - 02 Nov 2021
MicroPort® MedBot recently held a signing ceremony to mark the strateg...MicroPort® Toumai® Successfully Performed Difficult Procedures for Registered Multidisciplinary Clinical Trials - 01 Nov 2021
Lanzhou, China, 1 November 2021 - Shanghai MicroPort MedBot (Group) Co...MicroPort® MedBot Attends CUA 2021 with MicroPort® Urocare - 01 Nov 2021
MicroPort® MedBot and MicroPort Urocare joined together at the 28th Ch...MicroPort® Presents Argus OCT at the 32nd GW-ICC Entering the Era of Precision PCI - 01 Nov 2021
MicroPort® recently joined the 32nd GW-ICC to present the Argus intrav...MicroPort® CardioFlow Medtech Launches VitaFlow Liberty™ at China Structural Week - 31 Oct 2021
MicroPort CardioFlow Medtech Corporation (CardioFlow Medtech) recently...MicroPort® Makes Strategic Investment in Intravascular Imaging Start-up Argus - 29 Oct 2021
To Strengthen Multi-dimensional Layout of Precision Medicine in Pan-va...MicroPort® Expands MIH in Suzhou Industrial Park to Build Strategic Strength for Original Innovation of High-Tech Medical Solutions - 27 Oct 2021
MicroPort Institute of Health (MIH), a division of MicroPort Scientifi...